Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The regulation of antiviral innate immunity through non-m6A RNA modifications. | Front Immunol | 2023 | 37915585 | PubTator, text mining | PubMed |
| Estradiol in Systemic Lupus Erythematosus. | Acta Endocrinol (Buchar) | 2023 | 37908893 | PubTator, text mining | PubMed |
| Antiviral activity of zinc against hepatitis viruses: current status and future prospects. | Front Microbiol | 2023 | 37908540 | PubTator, text mining | PubMed |
| CAR Gene Delivery by T-cell Targeted Lentiviral Vectors is Enhanced by Rapamycin Induced Reduction of Antiviral Mechanisms. | Adv Sci (Weinh) | 2023 | 37904721 | PubTator, text mining | PubMed |
Chronic active Epstein-Barr virus infection as the basis of neoplasm development. Transformation of chronic lymphocytic leukaemia to NK-cell lymphoma/leukaemia was observed by flow cytometry - a diagnostic report. | Cent Eur J Immunol | 2023 | 37901865 | PubTator, text mining | PubMed |
| Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report. | Case Rep Oncol | 2023 | 37900793 | PubTator, text mining | PubMed |
| Circulating Small Extracellular Vesicles Reflect the Severity of Myocardial Damage in STEMI Patients. | Biomolecules | 2023 | 37892152 | PubTator, text mining | PubMed |
| Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids. | Emerg Microbes Infect | 2023 | 37883246 | PubTator, text mining | PubMed |
| Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis. | Front Med (Lausanne) | 2023 | 37881633 | PubTator, text mining | PubMed |
| Determining reference ranges for immunological cells of healthy indigenous individuals from a region in Brazil. | Einstein (Sao Paulo) | 2023 | 37878969 | PubTator, text mining | PubMed |
| Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia. | Nat Cancer | 2023 | 37872381 | PubTator, text mining | PubMed |
| A challenging diagnosis of plasmablastic lymphoma: importance of integrating morpholgy immunohistochemistry and flow cytometry findings (case report). | Pan Afr Med J | 2023 | 37869229 | PubTator, text mining | PubMed |
| Flower-shaped lymphocytes in CD5+ diffuse large B-cell lymphoma's leukemic phase. | Blood Res | 2023 | 37853440 | PubTator, text mining | PubMed |
| A spatial sequencing atlas of age-induced changes in the lung during influenza infection. | Nat Commun | 2023 | 37852965 | PubTator, text mining | PubMed |
| Single-cell chromatin accessibility and transcriptomic characterization of Behcet's disease. | Commun Biol | 2023 | 37848613 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing of Donor-Reactive T Cells Reveals Role of Apoptosis in Donor-Specific Hyporesponsiveness of Kidney Transplant Recipients. | Int J Mol Sci | 2023 | 37833911 | PubTator, text mining | PubMed |
| The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders. | Br J Biomed Sci | 2023 | 37822353 | PubTator, text mining | PubMed |
| Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients. | PLoS One | 2023 | 37819994 | PubTator, text mining | PubMed |
| Hairy Cell Leukemia: Hematological and Immunophenotypic Profile of 13 Patients. | Cureus | 2023 | 37814728 | PubTator, text mining | PubMed |
| Mechanism of herpesvirus UL24 protein regulating viral immune escape and virulence. | Front Microbiol | 2023 | 37808279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=19